Method for administering a therapeutic agent into tissue

a tissue and therapeutic agent technology, applied in the direction of infusion syringes, drug compositions, catheters, etc., can solve the problems of scar tissue formation, inability to reverse the procedure, and slow recovery tim

Inactive Publication Date: 2009-08-13
CERAMTEC
View PDF54 Cites 58 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

With this invasive treatment come several disadvantages such as:i) irreversibility of the procedureii) formation of scar tissueiii) slower recovery timeiv) longer hospital stays
Well known treatments for example are percutaneous discetomy and chemonucleolysis but the cost of these procedures has kept researchers looking for another alternative.
These drugs can be associated with side effects of infection and even death from gastric ulcer bleeding or immunosurpression and infection.
The post surgical recovery from sternotomy after cardiac surgery is often complicated wound infection.
This would shorten recovery time and decrease complication rates after surgery.
As the success of ozone gas therapy continues to gain recognition in the medical arena as a non-invasive alternative for the treatment of disc herniation, current methods of administering an effective dose of the ozone are solely as a gas and are far from optimum.
There also lacks a sterile methodology through which the ozone can be delivered selectively to the pain-affected area, i.e. the herniated disk.
The gas is unstable with a half life measured in seconds.
There are no dedicated medical ozone generators that are disposable single use units.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for administering a therapeutic agent into tissue
  • Method for administering a therapeutic agent into tissue
  • Method for administering a therapeutic agent into tissue

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0094]Referring now to FIG. 1, an apparatus for administering a therapeutic agent, such as an ozone gas, into a tissue in accordance with an embodiment of the invention is indicated generally at 20. In a present embodiment, apparatus 20 comprises an ozone generator 24 that connects to a charcoal scavenger 28 and an ozone administrator 32. Generator 24 can be based on any known medical ozone generator. Generator 24 connects to scavenger 28 and administrator 32 via a network of flexible tubing and valves for selectively directing the flow of gas therebetween. More specifically, a first segment of tubing 36 connects generator 24 to a three-way valve 40. A second segment of tubing 44 connects valve 40 to scavenger 28. A third segment of tubing 48 connects valve 40 to another valve 52, which in turn connects to administrator 32. The tubing is made of any suitable material, such as silicon of the known medical type, and has a diameter and wall thickness to withstand the pressure of ozone ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An apparatus for administering a therapeutic agent is provided. The apparatus, in an embodiment, includes an ozone generator connected to a scavenger and an ozone administrator via network of tubing and valves. When activated and the valves placed in the proper position, the ozone generator will fill the ozone administrator with ozone. The ozone generator can then be turned off and the valves moved so that the administrator can be disconnected from the remainder of the apparatus. The administrator is typically in the form of a syringe and needle. Once the syringe and needle is filled with ozone, the needle can be inserted into a tissue and the ozone expressed therefrom into the tissue. Various other apparatuses and methods are also contemplated.

Description

PRIORITY CLAIM[0001]The present application is a divisional application of, and claims priority to and the benefit of U.S. patent application Ser. No. 10 / 867,215, filed Jun. 15, 2004, which claimed the benefit of and priority to U.S. Provisional Patent Application No. 60 / 508,300, filed Oct. 6, 2003. The contents of both of these prior applications are incorporated herein by reference.FIELD OF THE INVENTION[0002]The present invention relates generally to a method, apparatus and kit for administering a therapeutic agent into tissue and in particular, for the administration of a therapeutic agent such as medical ozone.BACKGROUND OF THE INVENTION[0003]Back joint disc or tendon pain is a common and potentially debilitating ailment that affects an estimated 80% of the worldwide population at least once in a lifetime. In many instances, the cause of the pain can be attributed to a degenerated intervertebral disc that has further deteriorated into a condition known as disc herniation. This ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61M37/00A61B17/34A61K33/00A61K33/40A61K45/06A61M5/00A61M5/178A61M5/28A61M5/31A61M5/315A61M25/06
CPCA61M2005/3128A61M2005/3114A61M2202/0216A61M2210/1003A61M2202/0208A61M25/065A61M5/31511A61M5/28A61B17/3478A61K33/00A61K33/40A61K45/06A61K2300/00A61P19/02A61P25/04
Inventor MUTO, MARIOMURPHY, KIERAN P.
Owner CERAMTEC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products